Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NCO 700

Known as: NCO-700 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Purpose: The overall purpose of this study was to determine the potential efficacy of epoxide-containing piperazines as a new… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 6
1999
1999
Little is known as yet about the role of apoptosis in pancreatic damage. This study evaluated the effects of supraphysiologic… Expand
1998
1998
Activation of trypsinogen is thought to trigger the autodigestive process in acute pancreatitis. The lysosomal enzyme cathepsin B… Expand
1998
1998
The participation of oxidative mechanisms in major histocompatibility complex (MHC) class II‐restricted antigen presentation was… Expand
Highly Cited
1997
Highly Cited
1997
This study evaluated the action of menadione on cell proliferation and integrity of the rat pancreatic acinar cell line, AR4-2J… Expand
1994
1994
To explore the role of calcium-dependent protease in the stunned myocardium, open-chest dogs underwent 15 min of left anterior… Expand
1991
1991
The effect of NCO-700 (1), a protease inhibitor, on subcellular distribution of lysosomal enzymes was studied in the ischemic… Expand
1985
1985
During myocardial ischemia in dogs effects of NCO-700, a protease inhibitor on myocardial pH, were investigated. Ischemia was… Expand
1985
1985
NCO-700 is a newly synthesized inhibitor of both cathepsin B and calcium-activated neutral protease. We examined whether NCO-700… Expand
1982
1982
Calcium-activated neutral protease (CANP) might be involved in the irreversible degradation of myocardial proteins in the… Expand